APTIV PLC (APTV)
Aptiv Showcasing Next Generation Intelligent Edge Solutions at Automate 2026
Aptiv Showcasing Next Generation Intelligent Edge Solutions at Automate 2026
Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update
Vontier Earns Top Accolade at International Sustainability Awards
Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis
The Shift to Digital Credentials Accelerates: OneSpan Launches Early Access at Identiverse
Rectitude Holdings Ltd Secures Additional AIMS System Orders for Major Infrastructure and Residential Projects Across Singapore
ELECTRA AI to Participate in ROTHs 16th Annual London Conference, June 16-18, 2026
The Radoff-JEC Group Highlights Seer Inc.’s and Chairman and CEO Omid Farokhzad, M.D.’s History of Value Destruction
Humacyte's Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting
Humacytes Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting